Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase

European Journal of Medicinal Chemistry
2015.0

Abstract

The synthesis and antiviral evaluation of a series of dihydropyrimidinone and thiopyrimidine derivatives bearing aryl α,γ-diketobutanoic acid moiety are described using the Biginelli multicomponent reaction as key step. The most active among 20 synthesized novel compounds were 4c, 4d and 5b, which possess nanomolar HIV-1 integrase (IN) stand transfer (ST) inhibition activities. In order to understand their mode of interactions within the IN active site, we docked all the compounds into the previously reported X-ray crystal structure of IN. We observed that compounds 4c, 4d and 5b occupied an area close to the two catalytic Mg(2+) ions surrounded by their chelating triad (E221, D128 and D185), DC16, Y212 and the β-diketo acid moiety of 4c, 4d and 5b chelating Mg(2+). As those compounds lack anti-HIV activities in cell, their prodrugs were synthetized. The prodrug 4c' exhibited an anti-HIV activity of 0.19 μM in primary human lymphocytes with some cytotoxicity. All together, these results indicate that the new analogs potentially interact within the catalytic site with highly conserved residues important for IN catalytic activity.

Knowledge Graph

Similar Paper

Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase
European Journal of Medicinal Chemistry 2015.0
Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors
Bioorganic & Medicinal Chemistry 2015.0
4-Aryl-2,4-dioxobutanoic Acid Inhibitors of HIV-1 Integrase and Viral Replication in Cells
Journal of Medicinal Chemistry 2000.0
Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and evaluation of substituted 4-arylimino-3-hydroxybutanoic acids as potential HIV-1 integrase inhibitors
Bioorganic & Medicinal Chemistry Letters 2018.0
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors
Bioorganic & Medicinal Chemistry 2007.0
Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis, biological evaluation, and molecular modeling studies of new 1,3,4-oxadiazole- and 1,3,4-thiadiazole-substituted 4-oxo-4H-pyrido[1,2-a]pyrimidines as anti-HIV-1 agents
Medicinal Chemistry Research 2013.0
Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis, anti-HIV activity, integrase enzyme inhibition and molecular modeling of catechol, hydroquinone and quinol labdane analogs
Bioorganic & Medicinal Chemistry Letters 2014.0